Table 1 Demographic characteristics and pretreatment assessment of 29 patients who underwent B-TACE
Number of nodules, 1/2/3 | 24/4/1 |
Age, years | 72 (39–83) |
Gender, male/female | 21/8 |
Etiology, HBV/HCV/AL/others | 5/17/3/4 |
Child–Pugh class, A/B/C | 25/4/0 |
Albumin, g/dL | 3.6 (2.2–4.2) |
Total bilirubin, mg/dL | 1.0 (0.5–3.29) |
Prothrombin activity, % | 78 (51–111) |
Platelets, ×103/µL | 112 (31–219) |
AFP, ng/mL | 13.7 (2–3791) |
DCP, AU/L | 39 (9–2043) |